Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Will FTC Injunction Against Shkreli’s Company Deter Brands From Pursuing Anti-Generic Actions?
Dec 09 2021
•
By
Brenda Sandburg
FTC resolves complaint against Martin Shkreli's company and associate • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legal & IP
More from Pink Sheet